| 12036203 |
Methods of treating or reducing the risk of cardiovascular events and related diseases using SGLT-2 inhibitors |
Brett Lauring, Samuel S. Engel, Steven G. Terra |
2024-07-16 |
| 10709684 |
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease |
Ramachandra G. Naik, Elizabeth S. Ommen, Steven G. Terra |
2020-07-14 |
| 10500186 |
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease |
Ramachandra G. Naik, Elizabeth S. Ommen, Steven G. Terra |
2019-12-10 |
| 10285973 |
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease |
Ramachandra G. Naik, Elizabeth S. Ommen, Steven G. Terra |
2019-05-14 |
| 7671022 |
Methods for treating cardiovascular disease using a soluble CTLA4 molecule |
— |
2010-03-02 |
| 7482327 |
Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules |
David Hagerty |
2009-01-27 |
| 7307064 |
Methods for treating cardiovascular disease using a soluble CTLA4 molecule |
— |
2007-12-11 |
